G protein subunit alpha i2 (GNAI2)

G protein subunit alpha i2 (GNAI2) is an alpha subunit of heterotrimeric G proteins involved in modulating transmembrane signaling downstream of G protein-coupled receptors (GPCRs)[1][2][4][5][8]. GNAI2 primarily functions to inhibit adenylyl cyclase activity in response to various extracellular signals, thereby reducing intracellular cAMP and downstream protein kinase A activity[5]. It is widely expressed in human tissues and mediates numerous hormonal, neurotransmitter, and sensory input responses. GNAI2 plays critical roles in signal transduction, cell proliferation, and regulation of ion channel activity. Dysfunction or aberrant regulation of GNAI2 has been implicated in cardiac arrhythmias (e.g., familial ventricular tachycardia), pituitary adenoma, inflammation, cancer progression, and some metabolic diseases[1][7]. Many approved drugs acting on Gi/o-coupled GPCRs (such as various neurotransmitter and hormone receptors) indirectly engage GNAI2 in their mechanism of action. GNAI2 is an essential component of intracellular signaling but is not the direct target of any approved drugs due to its ubiquitous and central role in physiology.

Other names

GNAI2BGIPAdenylate cyclase-inhibiting G alpha proteinGTP-binding regulatory protein Gi alpha-2 chainGuanine nucleotide-binding protein G(i) subunit alpha-2HG1CH_LUCA15.1H_LUCA16.1gi alpha-2Galphai2GI2GI2 alphaGialpha-2Gi Alpha2 SubunitGiα-2I2

Inhibition of adenylyl cyclase activity leading to decreased cAMP levels[5]; Modulation of downstream signaling pathways via Gβγ subunit release; Regulation of potassium and calcium channels